Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect
Muta H, Ishii M, Maeno Y, Akagi T, Kato H. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002;91:649-52.
Plasma concentrations of N-terminal probrain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure
Mir TS, Marohn S, Laer S, Eiselt M, Grollmus O, Weil J. Plasma concentrations of N-terminal probrain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 2002;110:e76.
Regression-based reference limits and their reliability: Example on hemoglobin during the first year of life
Virtanen A, Kairisto V, Irjala K, Rajamaki A, Uusipaikka E. Regression-based reference limits and their reliability: example on hemoglobin during the first year of life. Clin Chem 1998;44:327-35.
Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: Marked and rapid increase after birth
Yoshibayashi M, Kamiya T, Saito Y, Nakao K, Nishioka K, Temma S, et al. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 1995;133:207-9.
Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing
Goetze JP, Kastrup J, Pedersen F, Rehfeld JF. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 2002;48:1035-42.